SpringWorks' Noncancerous Tumor Drug to Cost $29,000 Per Month
SpringWorks Therapeutics' drug for treating adult patients with a type of rare noncancerous soft-tissue tumor will be sold in the US at a list price of $29,000 for a 30-day supply.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/998839?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/998839?src=rss
Comments
Post a Comment